SMAD4 and neoplasm: Studies have shown that loss of SMAD4 promotes TGF-β-mediated tumorigenesis by abrogating the tumor-suppressive functions of TGF-β, such as cell cycle arrest, while maintaining the tumor-promoting functions of TGF-β, such as epithelial–mesenchymal transition [18].